| Staphylococcus aureus epicutaneous exposure drives skin inflammation via IL-36-mediated T cell responses H Liu, NK Archer, CA Dillen, Y Wang, AG Ashbaugh, RV Ortines, T Kao, ... Cell host & microbe 22 (5), 653-666. e5, 2017 | 221 | 2017 |
| Hydrogenase-3 contributes to anaerobic acid resistance of Escherichia coli K Noguchi, DP Riggins, KC Eldahan, RD Kitko, JL Slonczewski PloS one 5 (4), e10132, 2010 | 124 | 2010 |
| Corynebacterium pseudodiphtheriticum exploits Staphylococcus aureus virulence components in a novel polymicrobial defense strategy BL Hardy, SW Dickey, RD Plaut, DP Riggins, S Stibitz, M Otto, DS Merrell MBio 10 (1), 10.1128/mbio. 02491-18, 2019 | 81* | 2019 |
| Recent incarceration and buprenorphine maintenance treatment outcomes among human immunodeficiency virus–positive patients DP Riggins, CO Cunningham, Y Ning, AD Fox Substance abuse 38 (3), 297-302, 2017 | 14 | 2017 |
| Escherichia coli K-12 Survives Anaerobic Exposure at pH 2 without RpoS, Gad, or Hydrogenases, but Shows Sensitivity to Autoclaved Broth Products DP Riggins, MJ Narvaez, KA Martinez, MM Harden, JL Slonczewski PLoS One 8 (3), e56796, 2013 | 12 | 2013 |
Roger D PlautRegulatory Coordinator, Food and Drug Administration在 fda.hhs.gov 的电子邮件经过验证
